Category: Medications - Page 5

25Nov

Global Biosimilar Markets: Europe vs United States - How Regulations and Adoption Diverge

Posted by Dorian Fitzwilliam 13 Comments

Europe led the world in biosimilar adoption with clear regulations and fast uptake. The U.S. lagged due to legal barriers and strict rules - but is now catching up fast. Here's how the two markets compare today and where they're headed.

21Nov

Antitrust Laws and Competition Issues in Generic Pharmaceutical Markets

Posted by Dorian Fitzwilliam 11 Comments

Antitrust laws in the generic drug market aim to prevent pay-for-delay deals, patent abuse, and product hopping that block cheaper medications. These practices cost patients billions and delay access to life-saving drugs.

20Nov

DOACs in Renal Impairment: How to Adjust Dosing to Prevent Bleeding and Clots

Posted by Dorian Fitzwilliam 16 Comments

DOACs like apixaban, rivaroxaban, and dabigatran require precise dosing in kidney disease to avoid bleeding or strokes. Learn which drug is safest, how to calculate kidney function correctly, and what doses to use based on real-world data.

16Nov

Dairy Products and Antibiotic Absorption: Timing Matters

Posted by Dorian Fitzwilliam 15 Comments

Dairy products like milk and yogurt can block the absorption of certain antibiotics, leading to treatment failure. Learn which drugs are affected, how long to wait, and what to avoid to make your antibiotics work.

14Nov

Medication Errors in Hospitals vs. Retail Pharmacies: What You Need to Know

Posted by Dorian Fitzwilliam 8 Comments

Medication errors happen in both hospitals and retail pharmacies, but the risks and causes differ. Learn how often mistakes occur, why they slip through, and how to protect yourself from harm.

13Nov

Outcomes Economics: The Real Cost-Benefit of Using Generic Medications

Posted by Dorian Fitzwilliam 10 Comments

Generics save billions in healthcare spending, but do they truly deliver better health outcomes? Real-world data shows how cost-benefit analysis drives smarter prescribing and patient savings.

3Nov

Azulfidine vs Alternatives: What Works Best for Inflammatory Bowel Disease?

Posted by Dorian Fitzwilliam 14 Comments

Azulfidine (sulfasalazine) helps treat ulcerative colitis and Crohn’s, but newer drugs like mesalamine are safer and better tolerated. Learn how the top alternatives compare in effectiveness, cost, and side effects.

2Nov

Compare Atacand (Candesartan) with Alternatives: What Works Best for High Blood Pressure?

Posted by Dorian Fitzwilliam 14 Comments

Compare Atacand (candesartan) with cheaper, equally effective alternatives like losartan, amlodipine, and valsartan. Learn which blood pressure meds work best for cost, side effects, and long-term health.

1Nov

Next-Generation GLP-1 Agents: What You Need to Know About Safety and Side Effects

Posted by Dorian Fitzwilliam 9 Comments

Next-generation GLP-1 agents like retatrutide and orforglipron offer powerful weight loss but come with serious side effects and safety concerns. Learn what's known - and what's still unknown - about their risks and how to use them safely.

29Oct

Drug Holidays: When Taking a Break from Medication Is Safe and Strategic

Posted by Dorian Fitzwilliam 12 Comments

Drug holidays can help manage medication side effects-but only when planned with a doctor. Learn which drugs allow safe breaks, the risks of stopping on your own, and how to do it right.